Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin

Journal of Controlled Release

Volumn 142, Issue 3, 2010, Pages 368-373

  Şenyiǧit, Taner ^a,b   Sonvico, Fabio ^b   Barbieri, Stefano ^b   Özer, Özgen ^a   Santi, Patrizia ^b   Colombo, Paolo ^b  

^a EGE UNIVERSITY   (Turkey)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Clobetasol propionate; Epidermal targeting; Lecithin chitosan nanoparticles; Skin retention; Topical glucocorticoids

Indexed keywords

ACTIVE AGENTS; CHITOSAN GEL; CLOBETASOL PROPIONATE; ENCAPSULATION EFFICIENCY; EPIDERMAL TARGETING; GLUCOCORTICOIDS; IN-VITRO; PIG SKIN; POLYDISPERSITY INDICES; SIDE EFFECT;

CHITIN; CHITOSAN; ENCAPSULATION; GELS; POLYDISPERSITY; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

NANOPARTICLES;

CHITOSAN; CLOBETASOL PROPIONATE; NANOPARTICLE; PHOSPHATIDYLCHOLINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREAM; DRUG ACCUMULATION; DRUG PENETRATION; DRUG TRANSPORT; EAR; ENCAPSULATION; EPIDERMIS; GEL; IN VITRO STUDY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SKIN; SKIN PERMEABILITY; SWINE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANIMALS; CHITOSAN; CLOBETASOL; DERMIS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; EPIDERMIS; GELS; GLUCOCORTICOIDS; LECITHINS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; SKIN; SURFACE PROPERTIES; SWINE; VISCOSITY;

EID: 77349092809     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.11.013     Document Type: Article

References (41)

1. Zöller N.N., Kippenberger S., Thaçi D., Mewes K., Spiegel M., Sattler A., Schultz M., Bereiter-Hahn J., Kaufmann R., and Bernd A. Evaluation of beneficial and adverse effects of glucocorticoids on a newly developed full-thickness skin model. Toxicol. In Vitro 22 (2008) 747-759
2. Schoepe S., Schacke H., May E., and Asadullah K. Glucocorticoid therapy-induced skin atrophy. Exp. Dermatol. 15 (2006) 406-420
3. Franz T.J., Lehman P.A., Feldman S.R., and Spellman M.N. Bioavailability of Clobetasol propionate in different vehicles. Skin Pharmacol. Appl. Skin Physiol. 16 (2003) 212-216
4. Fang J.Y., Shen K.L., Huang Y.B., Wu P.C., and Tsai Y.H. Evaluation of topical application of Clobetasol 17-propionate from various cream bases. Drug Dev. Ind. Pharm. 25 (1999) 7-14
5. Fang J.Y., Fang C.L., Sung K.C., and Chen H.Y. Effect of low frequency ultrasound on the in vitro percutaneous absorption of clobetasol 17-propionate. Int. J. Pharm. 191 (1999) 33-42
6. Schackert C., Korting H.C., and Schafer-Korting M. Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo characterisation of drugs with an increased benefit-risk ratio. BioDrugs 13 (2000) 267-277
7. Fang J.Y., Leu Y.L., Wang Y.Y., and Tsai Y.H. In vitro topical application and in vivo pharmacodynamic evaluation of nonivamide hydrogels using wistar rat as an animal model. Eur. J. Pharm. Sci. 15 (2002) 417-423
8. Stoughton R.B. Are generic formulations equivalent to trade name topical glucocorticoids?. Arch. Dermatol. 123 (1987) 1312-1314
9. Shim J., Kang H.S., Park W., Han S., Kim J., and Chang I. Transdermal delivery of minoxidil with block copolymer nanoparticles. J. Control. Release 97 (2004) 477-484
10. Alvarez-Roman R., Naik A., Kalia Y.N., Guy R.H., and Fessi H. Skin penetration and distribution of polymeric nanoparticles. J. Control. Release 99 (2004) 53-62
11. Schafer-Korting M., Mehnert W., and Korting H.C. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv. Drug Deliv. Rev. 59 (2007) 427-443
12. Alvarez-Roman R., Naik A., Kalia Y.N., Guy R.H., and Fessi H. Enhancement of topical delivery from biodegradable nanoparticles. Pharm. Res. 21 (2004) 1818-1825
13. Santos Maia C., Mehnert W., Schaller M., Korting H.C., Gysler A., Haberland A., and Schafer-Korting M. Drug targeting by solid lipid nanoparticles for dermal use. J. Drug Target. 10 (2002) 489-495
14. Schaller M., Preidel H., Januschke E., and Korting H.C. Light and electron microscopic findings in a model of human cutaneous candidosis based on reconstructed human epidermis following the topical application of different econazole formulations. J. Drug Target. 6 (1999) 361-372
15. R. Beumer, C. Chen, H. Gutzwiller, P.E. Maillan, M. Nowotny, B. Schlegel, J. Vollhardt, Topical compositions comprising nanoparticles of an isoflavone, US Patent Application 20080311209, (2008).
16. P. Dmowski, G.T. Dipiano, Topical administration of danazol, US Patent Application, 20080153789, (2008).
17. Sonvico F., Cagnani A., Rossi A., Motta S., Di Bari M.T., Cavatorta F., Alonso M.J., Deriu A., and Colombo P. Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction. Int. J. Pharm. 324 (2006) 67-73
18. Batzri S., and Korn E. Single bilayer liposomes prepared without sonication. Biochim. Biophys. Acta 298 (1973) 1015-1019
19. Felt O., Buri P., and Gurny R. Chitosan: a unique polysaccharide for drug delivery. Drug Dev. Ind. Pharm. 24 (1998) 979-993
20. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15 (1998) 1326-1331
21. Singla A.K., and Chawla M. Chitosan: some pharmaceutical and biological aspects - an update. J. Pharm. Pharmacol. 53 (2001) 1047-1067
22. Agnihotri S.A., Mallikarjuna N.N., and Aminabhavi T.M. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J. Control. Release 100 (2004) 5-28
23. Ueno H., Mori T., and Fujinaga T. Topical formulations and wound healing applications of chitosan. Adv. Drug Deliv. Rev. 52 (2001) 105-115
24. Dai T., Tegos G.P., Burkatovskaya M., Castano A.P., and Hambiln M.R. Chitosan acetate bandage as topical antimicrobial dressing for infected burns. Antimicrob. Agents Chemother. 53 (2009) 393-400
25. Brown M.A., Daya M.R., and Worley J.A. Experience with chitosan dressings in a civilian EMS system. J. Emerg. Med. 37 (2007) 1-7
26. Bos J.D. Non-steroidal topical immunomodulators provide skin-selective, self limiting treatment in atopic dermatitis. Eur. J. Dermatol. 13 (2003) 455-461
27. Sekkat N., Kalia Y.N., and Guy R.H. Biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo. J. Pharm. Sci. 91 (2002) 2376-2381
28. Jacobi U., Kaiser M., Toll R., Mangelsdorf S., Audring H., Otberg N., Sterry W., and Lademann J. Porcine ear skin: an in vitro model for human skin. Skin Res. Technol. 13 (2007) 19-24
29. Padula C., Sartori F., Marra F., and Santi P. The influence of iontophoresis on acyclovir transport and accumulation in rabbit ear skin. Pharm. Res. 22 (2005) 1519-1524
30. Komatsu H., Kitajima A., and Okada S. Pharmaceutical characterization of commercially available intravenous fat emulsions: estimation of average particle size, size distribution and surface potential using photon correlation spectroscopy. Chem. Pharm. Bull. 43 (1995) 1412-1415
31. Müller R.H., Mader K., and Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm. 50 (2000) 161-177
32. Müller R.H., Jacobs C., and Kayser O. Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev. 47 (2001) 3-19
33. Gerelli Y., Di Bari M.T., Deriu A., Cantu L., Colombo P., Como C., Motta S., and May R. Structure and organization of phospholipid/polysaccharide nanoparticles. J. Phys.: Condens. Matter 20 (2008) 104211 8pp
34. Şenyiǧit T., Padula C., Özer Ö., and Santi P. Different approaches for improving skin accumulation of topical corticosteroids. Int. J. Pharm. 380 (2009) 155-160
35. Luengo J., Weiss B., Schneider M., Ehlers A., Stracke F., König K., Kostka K.H., Lehr C.M., and Schaefer U.F. Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol. Physiol. 19 (2006) 190-197
36. Iscan Y., Hekimoglu S., Sargon M.F., and Hincal A.A. DEET-loaded solid lipid particles for skin delivery: in vitro release and skin permeation characteristics in different vehicles. J. Microencapsul. 23 3 (2006) 315-327
37. C.D. Wright, Micellar nanoparticles, United States Patent 5629021, (1997).
38. Mei Z., Chen H., Weng T., Yang Y., and Yang X. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur. J. Pharm. Biopharm. 56 (2003) 189-196
39. Arellano A., Santoyo S., Martin C., and Ygartua P. Influence of propylene glycol and isopropyl myristate on the in vitro percutaneous penetration of diclofenac sodium from carbopol gels. Eur. J. Pharm. Sci. 7 (1998) 129-135
40. Sinico C., Caddeo C., Valenti D., Fadd A.M., Bilia A.R., and Vincieri F.F. Liposomes as carriers for verbascoside: stability and skin permeation studies. J. Liposome Res. 18 (2008) 83-90
41. Barichello J.M., Handa H., Kisyuku M., Shibata T., Ishida T., and Kiwada H. Inducing effect of liposomalization on the transdermal delivery of hydrocortisone: creation of a drug supersaturated state. J Control. Release 115 (2006) 94-102